2592-19-0 Usage
Description
Boc-Lys(Boc)-ONp, also known as Nα,Nε-DiBoc-L-lysine p-Nitrophenol Ester, is a light yellowish crystalline powder that serves as an antibody-drug conjugate and antitumor agent. Its chemical properties make it a valuable compound in the field of pharmaceuticals and medicine.
Uses
Used in Pharmaceutical Industry:
Boc-Lys(Boc)-ONp is used as an antibody-drug conjugate for targeted cancer therapy. It is designed to deliver antitumor agents directly to cancer cells, minimizing damage to healthy cells and reducing side effects.
Used in Antitumor Applications:
Boc-Lys(Boc)-ONp is used as an antitumor agent for the treatment of various types of cancer. Its targeted approach allows for more effective and precise delivery of therapeutic agents to cancer cells, improving treatment outcomes and patient quality of life.
Check Digit Verification of cas no
The CAS Registry Mumber 2592-19-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,9 and 2 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2592-19:
(6*2)+(5*5)+(4*9)+(3*2)+(2*1)+(1*9)=90
90 % 10 = 0
So 2592-19-0 is a valid CAS Registry Number.
InChI:InChI=1/C22H33N3O8/c1-21(2,3)32-19(27)23-14-8-7-9-17(24-20(28)33-22(4,5)6)18(26)31-16-12-10-15(11-13-16)25(29)30/h10-13,17H,7-9,14H2,1-6H3,(H,23,27)(H,24,28)
2592-19-0Relevant articles and documents
COMPOUNDS
-
Paragraph 0242, (2018/01/17)
The present technology relates to compounds, kits, compositions, and methods useful for the treatment of numerous pathologies including dementia, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other neurodegenerative diseases, spinal cord injury, traumatic brain injury, diabetes and metabolic syndrome, defective wound healing, and/or sensorineural hearing and vision loss.